Equasens Société anonyme (0R9T.L)
EUR 44.15
(1.03%)
EUR 44.15
(1.03%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 39.51 Million EUR | -18.41% |
| 2022 | 48.43 Million EUR | -18.41% |
| 2021 | 59.36 Million EUR | 18.34% |
| 2020 | 50.16 Million EUR | 28.7% |
| 2019 | 38.97 Million EUR | 6.36% |
| 2018 | 36.64 Million EUR | 158.12% |
| 2017 | 14.19 Million EUR | 312.46% |
| 2016 | 3.44 Million EUR | 212.06% |
| 2015 | 1.1 Million EUR | 6.36% |
| 2014 | 1.03 Million EUR | -4.86% |
| 2013 | 1.09 Million EUR | -18.54% |
| 2012 | 1.33 Million EUR | -55.61% |
| 2011 | 3.01 Million EUR | -32.53% |
| 2010 | 4.46 Million EUR | -34.11% |
| 2009 | 6.77 Million EUR | -32.39% |
| 2008 | 10.02 Million EUR | -5.44% |
| 2007 | 10.6 Million EUR | -14.63% |
| 2006 | 12.42 Million EUR | 155.84% |
| 2005 | 4.85 Million EUR | -19.84% |
| 2004 | 6.05 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 33.81 Million EUR | 0.0% |
| 2024 Q1 | 33.81 Million EUR | -14.43% |
| 2023 Q3 | 46.92 Million EUR | 13.64% |
| 2023 FY | 39.51 Million EUR | -18.41% |
| 2023 Q4 | 39.51 Million EUR | -15.79% |
| 2023 Q1 | 48.22 Million EUR | -0.42% |
| 2023 Q2 | 41.29 Million EUR | -14.37% |
| 2022 FY | 48.43 Million EUR | -18.41% |
| 2022 Q4 | 48.43 Million EUR | -0.4% |
| 2022 Q3 | 48.62 Million EUR | -10.43% |
| 2022 Q2 | 54.29 Million EUR | -0.36% |
| 2022 Q1 | 54.48 Million EUR | -8.21% |
| 2021 Q3 | 63.38 Million EUR | 30.6% |
| 2021 Q1 | 53.41 Million EUR | 6.48% |
| 2021 Q2 | 48.53 Million EUR | -9.14% |
| 2021 Q4 | 59.36 Million EUR | -6.35% |
| 2021 FY | 59.36 Million EUR | 18.34% |
| 2020 Q4 | 50.16 Million EUR | -8.81% |
| 2020 FY | 50.16 Million EUR | 28.7% |
| 2020 Q2 | 52.2 Million EUR | -11.07% |
| 2020 Q1 | 58.7 Million EUR | 50.63% |
| 2020 Q3 | 55.01 Million EUR | 5.37% |
| 2019 Q3 | 47.48 Million EUR | 18.5% |
| 2019 FY | 38.97 Million EUR | 6.36% |
| 2019 Q4 | 38.97 Million EUR | -17.91% |
| 2019 Q2 | 40.06 Million EUR | -14.55% |
| 2019 Q1 | 46.89 Million EUR | 27.96% |
| 2018 Q3 | 36.94 Million EUR | 3.82% |
| 2018 FY | 36.64 Million EUR | 158.12% |
| 2018 Q2 | 35.58 Million EUR | -0.66% |
| 2018 Q4 | 36.64 Million EUR | -0.82% |
| 2018 Q1 | 35.82 Million EUR | 152.34% |
| 2017 FY | 14.19 Million EUR | 312.46% |
| 2017 Q4 | 14.19 Million EUR | 0.0% |
| 2017 Q3 | 14.19 Million EUR | 178.37% |
| 2017 Q2 | 5.1 Million EUR | 0.0% |
| 2017 Q1 | 5.1 Million EUR | 48.17% |
| 2016 Q4 | 3.44 Million EUR | 0.0% |
| 2016 FY | 3.44 Million EUR | 212.06% |
| 2016 Q1 | 3.77 Million EUR | 242.43% |
| 2016 Q2 | 3.77 Million EUR | 0.0% |
| 2016 Q3 | 3.44 Million EUR | -8.87% |
| 2015 Q1 | 337 Thousand EUR | -67.5% |
| 2015 FY | 1.1 Million EUR | 6.36% |
| 2015 Q2 | 337 Thousand EUR | 0.0% |
| 2015 Q3 | 1.1 Million EUR | 227.3% |
| 2015 Q4 | 1.1 Million EUR | 0.0% |
| 2014 Q3 | 1.03 Million EUR | 12.35% |
| 2014 Q1 | 923 Thousand EUR | -15.32% |
| 2014 Q2 | 923 Thousand EUR | 0.0% |
| 2014 FY | 1.03 Million EUR | -4.86% |
| 2014 Q4 | 1.03 Million EUR | 0.0% |
| 2013 Q2 | 1.25 Million EUR | 0.0% |
| 2013 Q4 | 1.09 Million EUR | 0.0% |
| 2013 Q3 | 1.09 Million EUR | -13.15% |
| 2013 FY | 1.09 Million EUR | -18.54% |
| 2013 Q1 | 1.25 Million EUR | -6.2% |
| 2012 Q4 | 1.33 Million EUR | 0.0% |
| 2012 Q2 | 1.53 Million EUR | 0.0% |
| 2012 FY | 1.33 Million EUR | -55.61% |
| 2011 Q2 | 3.17 Million EUR | 0.0% |
| 2011 Q4 | 3.01 Million EUR | 0.0% |
| 2011 FY | 3.01 Million EUR | -32.53% |
| 2010 Q2 | 5.71 Million EUR | 0.0% |
| 2010 FY | 4.46 Million EUR | -34.11% |
| 2010 Q4 | 4.46 Million EUR | 0.0% |
| 2009 FY | 6.77 Million EUR | -32.39% |
| 2009 Q4 | 6.77 Million EUR | 0.0% |
| 2008 FY | 10.02 Million EUR | -5.44% |
| 2007 FY | 10.6 Million EUR | -14.63% |
| 2006 FY | 12.42 Million EUR | 155.84% |
| 2005 FY | 4.85 Million EUR | -19.84% |
| 2004 FY | 6.05 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Cegedim SA | 188.54 Million EUR | 79.041% |
| Guerbet SA | 360.51 Million EUR | 89.039% |
| Nexus AG | 15.43 Million EUR | -155.972% |
| Bastide Le Confort Médical SA | 291.04 Million EUR | 86.423% |
| Revenio Group Oyj | 10.05 Million EUR | -293.204% |
| Drägerwerk AG & Co. KGaA | 257.71 Million EUR | 84.666% |
| Sartorius Aktiengesellschaft | 5.02 Billion EUR | 99.213% |
| LNA Santé SA | 341.16 Million EUR | 88.417% |
| Siemens Healthineers AG | 436 Million EUR | 90.936% |
| Medios AG | 14.65 Million EUR | -169.649% |
| Stratec SE | 80.8 Million EUR | 51.093% |